Reported 3 days ago
A significant drop in shares of Novo Nordisk, the maker of Ozempic, has led to a decline in consumer confidence in Denmark, reaching its lowest level in three months. Despite wage growth and a strong job market, the company's stock price has plummeted by 45% this year due to increasing competition and legal challenges against counterfeit drugs. This decline has raised concerns about the overall economic sentiment among Danes, particularly as Novo Nordisk plays a crucial role in job creation.
Source: YAHOO